Healthcare Equipment & Supplies
Valuation | |
|---|---|
| Market Cap | 814.83 Cr |
| Price/Earnings (Trailing) | 113.09 |
| EV/EBITDA | 71 |
| Price/Free Cashflow | 101.91 |
| MarketCap/EBT | 86.86 |
| Enterprise Value | 741.67 Cr |
Profitability | |
|---|---|
| Free Cashflow Yield | 0.98% |
Growth & Returns | |
|---|---|
| Price Change 1W | -5.2% |
| Price Change 1M | -16.8% |
| Price Change 6M | -34% |
| Price Change 1Y | 373.5% |
| 3Y Cumulative Return | 24.1% |
| 5Y Cumulative Return | 35.8% |
| 7Y Cumulative Return | 36.3% |
| 10Y Cumulative Return | 23.6% |
Cash Flow & Liquidity |
|---|
| Cash & Equivalents | 73.17 Cr |
Balance Sheet | |
|---|---|
| Total Assets | 214.02 Cr |
| Current Assets | 154.38 Cr |
| Current Liabilities | 72.96 Cr |
| Inventory | 37.11 Cr |
Capital Structure & Leverage | |
|---|---|
| Debt Ratio | 0.00 |
Past Returns: Outperforming stock! In past three years, the stock has provided 24.1% return compared to 12.8% by NIFTY 50.
Smart Money: Smart money is taking extra interest in the stock as they increase their holdings.
Momentum: Stock is suffering a negative price momentum. Stock is down -16.8% in last 30 days.
Dividend: Stock hasn't been paying any dividend.
Size: It is a small market cap company and can be volatile.
Insider Trading: Significant insider selling noticed recently.
Technicals: SharesGuru indicator is Bearish.
Past Returns: Outperforming stock! In past three years, the stock has provided 24.1% return compared to 12.8% by NIFTY 50.
Smart Money: Smart money is taking extra interest in the stock as they increase their holdings.
Momentum: Stock is suffering a negative price momentum. Stock is down -16.8% in last 30 days.
Dividend: Stock hasn't been paying any dividend.
Size: It is a small market cap company and can be volatile.
Insider Trading: Significant insider selling noticed recently.
Technicals: SharesGuru indicator is Bearish.
Financial Health | |
|---|---|
| Current Ratio | 2.12 |
Technical Indicators | |
|---|---|
| RSI (14d) | 28.6 |
| RSI (5d) | 25.64 |
| RSI (21d) | 31.28 |
| MACD Signal | Sell |
| Stochastic Oscillator Signal | Hold |
| SharesGuru Signal | Sell |
| RSI Signal | Buy |
| RSI5 Signal | Buy |
| RSI21 Signal | Hold |
| SMA 5 Signal | Sell |
| SMA 10 Signal | Sell |
| SMA 20 Signal | Sell |
| SMA 50 Signal | Sell |
| SMA 100 Signal | Sell |
Summary of Hemant Surgical Industries's latest earnings call, featuring management's outlook on business performance, financial results, and analyst Q&A sessions that highlight key strategic initiatives and market challenges.
Understand Hemant Surgical Industries ownership landscape with insights into key distribution patterns, offering investors a clear view of stakeholder dynamics.
| Shareholder Name | Holding % |
|---|---|
| HANSKUMAR SHAMJI SHAH | 27.05% |
| KAUSHIK HANSKUMAR SHAH | 16.13% |
| HEMANT PRAFUL SHAH | 13.3% |
| Singularity Large Value Fund I | 3.83% |
| Wealthwave Capital Fund | 3.07% |
| SURESH ZUNZUNWALA | 2.58% |
| MONA LAROIA | 2.52% |
Detailed comparison of Hemant Surgical Industries against industry peers, highlighting key financial metrics, valuation ratios, and performance indicators to provide competitive context within the sector.
This is an informational page just to provide a quick 'first look' at the stock. You must do your own deeper research. Know your risk appetite. Consult a SEBI-registered financial advisor before making any investment decisions.
| Swati Pokharna | 2.3% |
| Renudevi Hisaria | 2.3% |
| Singularity Large Value Fund III | 1.91% |
| Singularity Equity Fund I | 1.91% |
| PM Investment | 1.53% |
| HARSHA VENKATESH | 0.84% |
| SACHIN KUMAR BHARTIYA | 0.8% |
| Upahar Homfin Private Limited | 0.77% |
| Free India Assurance Services Limited | 0.77% |
| Naresh Saraaf | 0.77% |
| NAMAN HEMANT SHAH | 0.73% |
| LEENA HANSKUMAR SHAH | 0.67% |
| NEHA HANSKUMAR SHAH | 0.6% |
Distribution across major stakeholders
Distribution across major institutional holders
| 7.6 |
| 223 |
| 227 |
| 360 |
| 309 |
| Finance costs | 4100% | 2.2 | 0.97 | 72 | 73 | 87 | 56 |
| Other expenses | 33.3% | 13 | 10 | 581 | 671 | 901 | 814 |
| Total Expenses | 4.2% | 101 | 97 | 1,766 | 1,804 | 2,632 | 2,182 |
| Total profit before tax | -16.7% | 11 | 13 | 115 | 75 | 108 | 106 |
| Current tax | -25.7% | 2.65 | 3.22 | 1.34 | 0 | 8.58 | 28 |
| Deferred tax | 0.8% | -0.23 | -0.24 | 25 | 27 | 29 | 3.11 |
| Tax expense | -28.3% | 2.42 | 2.98 | 27 | 27 | 37 | 31 |
| Net profit (loss) for the period | -19% | 8.13 | 9.8 | - | - | - | - |
| Reserve excluding revaluation reserves | - | 0 | - | 954 | 965 | 0 | 0 |
| Earnings Per Share, Basic | -23.3% | 7.79 | 9.85 | 12.71 | 6.69 | 9.74 | 10.34 |
| Earnings Per Share, Diluted | -23.3% | 7.79 | 9.85 | 12.71 | 6.69 | 9.74 | 10.34 |
| 20% |
| 73 |
| 61 |
| 38 |
| 35 |
| 661 |
| 663 |
| Total equity and liabilities | 44.9% | 214 | 148 | 97 | 90 | 2,989 | 2,856 |
| 51.6% |
| 0.38 |
| -0.28 |
| - |
| - |
| - |
| - |
| Total adj. for working capital | 75.3% | -3.68 | -17.96 | - | - | - | - |
| Net Cashflows From Operations | 360.7% | 12 | -3.22 | - | - | - | - |
| Interest received | 25% | -0.59 | -1.12 | - | - | - | - |
| Income taxes paid (refund) | -58.1% | 1.93 | 3.22 | - | - | - | - |
| Other inflows/outflows of cash | - | -0.18 | 0 | - | - | - | - |
| Net Cashflows From Operating Activities | 192.5% | 8.92 | -7.56 | - | - | - | - |
| Purchase of tangible assets | - | - | 5.52 | - | - | - | - |
| Interest received | -441.7% | 0.59 | 1.12 | - | - | - | - |
| Other inflows/outflows of cash | 162.1% | 4.46 | -4.57 | - | - | - | - |
| Net Cashflows From Investing Activities | -213.7% | -30.28 | -8.97 | - | - | - | - |
| Proceeds from issuing shares | -104.8% | 0 | 22 | - | - | - | - |
| Proceeds from borrowings | 3753.8% | 20 | 0.48 | - | - | - | - |
| Interest paid | 2016.7% | 2.15 | 0.94 | - | - | - | - |
| Net Cashflows From Financing Activities | -15% | 18 | 21 | - | - | - | - |
| Net change in cash and cash eq. | -227% | -3.71 | 4.71 | - | - | - | - |